Categories

626 casos confirmados por COVID-19

626 casos confirmados por COVID-19

626 casos confirmados por COVID-19Miércoles 15 de abril, 2020. Este miércoles 15 de abril registran 626 casos confirmados por COVID-19, con un rango de edad de uno a 87 años. Se trata de 302 mujeres y 324 hombres, de los cuales 583 son costarricenses y 43 extranjeros.

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/741-noticias-2020/1613-626-casos-confirmados-por-covid-19

 
Categories

Costa Rica registra su cuarto fallecimiento de paciente COVID-19

Costa Rica registra su cuarto fallecimiento de paciente COVID-19

Costa Rica registra su cuarto fallecimiento de paciente COVID-1915 de abril del 2020. Esta mañana se registró en el Hospital San Juan de Dios la cuarta muerte de un paciente positivo por COVID-19. Se trata de un hombre de 84 años, costarricense, vecino de San José.

https://www.ministeriodesalud.go.cr/index.php/centro-de-prensa/noticias/741-noticias-2020/1612-costa-rica-registra-su-cuarto-fallecimiento-de-paciente-covid-19

 
Categories

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Ampicillin and Sulbactam for Injection USP 1.5 g/ Vial, Due to Presence of Glass Particles in the Vial

AuroMedics Pharma LLC is voluntarily recalling lot AFO l 17001-A, Expiry date Dec 2018, of Ampicillin and Sulbactam for Injection USP, 1.5 g (equivalent to 1 g ampicillin as the sodium salt plus 0.5 g Sulbactam as the sodium salt) in a Single-Dose vial, to the hospital level. The product has been found to contain glass particles.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/auromedics-pharma-llc-issues-voluntary-nationwide-recall-product-ampicillin-and-sulbactam-injection

 
Categories

International Laboratories, LLC Issues Voluntary Nationwide Recall of One (1) Lot of Clopidogrel Tablets USP, 75 mg Packaged in Bottles of 30 Tablets Due to Mislabeling NDC # 54458-888-16; Lot # 117099A

International Laboratories, LLC is voluntarily recalling Lot# 117099A of Clopidogrel Tablets, USP 75 mg, packaged in bottles of 30 tablets, to the consumer level due to mislabeling. The product is labeled as Clopidogrel tablets USP 75 mg but may contain Clopidogrel 75mg or Simvastatin Tablets USP 10 mg.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/international-laboratories-llc-issues-voluntary-nationwide-recall-one-1-lot-clopidogrel-tablets-usp

 
Categories

Health Canada is temporarily authorizing the use of technical-grade ethanol in hand sanitizer products: Always follow the label directions when using alcohol-based hand sanitizers

Health Canada is temporarily authorizing the use of technical-grade ethanol in hand sanitizer products: Always follow the label directions when using alcohol-based hand sanitizers
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2020/72739a-eng.php

 
Categories

Amneal Pharmaceuticals, LLC. Issues Voluntary Nationwide Recall of Nizatidine Oral Solution, 15 mg/mL, Due to Potential Levels of N-nitrosodimethylamine (NDMA) Impurity Amounts Above the Levels Established by FDA

Amneal Pharmaceuticals, LLC, Bridgewater, New Jersey is voluntarily recalling three lots of Nizatidine Oral Solution, 15 mg/mL (75 mg/5mL), packaged in 480 mL bottles to the Consumer Level. Nizatidine Oral Solution was distributed by Gemini Laboratories, LLC, a wholly owned subsidiary of Amneal Phar

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/amneal-pharmaceuticals-llc-issues-voluntary-nationwide-recall-nizatidine-oral-solution-15-mgml-due

 
Categories

Baxter Expands Voluntary Nationwide Recall to Include Second Lot of Nexterone Injection Due to Presence of Particulate Matter

Following the issuance of a voluntary recall dated November 10, 2017 of one lot of NEXTERONE (amiodarone HCl) 150 mg/100 mL Premixed Injection, Baxter International Inc. announced today it is expanding the recall to include a second lot (NC109123) of NEXTERONE due to the potential presence of particulate matter.

http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/baxter-expands-voluntary-nationwide-recall-include-second-lot-nexterone-injection-due-presence